Gelber RD; International Breast Cancer Study Group and University of Sydney, Sydney, Australia; Harvard T.H. Chan School of Public Health, Boston, USA.; Coates AS; International Breast Cancer Study Group and University of Sydney, Sydney, Australia.; Gelber S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Orecchia R; European Institute of Oncology IRCCS, Milan, Italy.; Veronesi P; European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy.; Di Leo A; Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy.; Colleoni M; European Institute of Oncology IRCCS, Milan, Italy.; Winer EP; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Burstein HJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Viale G; European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy.; Senn HJ; Tumor and Breast Center ZeTuP, St. Gallen, Switzerland.; Piccart M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: martine.piccart@bordet.be.; Curigliano G; European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.
Source
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: PubMed not MEDLINE; MEDLINE